-
Covaxin (development name, BBV152) is a
whole inactivated virus-based COVID-19
vaccine developed by
Bharat Biotech in
collaboration with the
Indian Council...
- Pfizer–BioNTech, Oxford–AstraZeneca,
Sinopharm BIBP, Moderna, Janssen, CoronaVac,
Covaxin, Novavax, Convidecia, and Sanofi–GSK.
Seven others are
under ****essment...
-
license by
Serum Institute of
India under the
trade name Covishield) and
Covaxin (a
vaccine developed locally by
Bharat Biotech). They have
since been joined...
-
company were
responsible for
developing India's own COVID-19 vaccine,
Covaxin, World's 1st
clinically proven conjugated Typhoid Vaccine,
TypbarTCV and...
- The Case
Covaxin, also
known as Covaxgate,
refers to an
investigation made by the
Brazilian Federal Public Ministry (MPF), held on June 16, 2021, which...
- 2
clinical trials in
India for a
developmental COVID-19
vaccine named Covaxin, from the
Drugs Controller General of
India (DCGI),
Government of India...
-
peacekeeping missions.
India has two
approved COVID-19 vaccines:
Covishield and
Covaxin. Both of them were
exported and used in
foreign grants by the Government...
- NDTV.com.
Retrieved 20
November 2020. "Want to
speed up
vaccine trial:
Covaxin volunteer Anil Vij". The
Indian Express. 20
November 2020.
Retrieved 20...
- pathogens,
including influenza,
polio (IPV), rabies,
hepatitis A, CoronaVac,
Covaxin and pertussis.
Because inactivated pathogens tend to
produce a
weaker response...
-
January 2021 with
AstraZeneca vaccine (Covishield) and the
indigenous Covaxin. Later,
Sputnik V and the
Moderna vaccine was
approved for
emergency use...
